Sanket Koul

Revised scheme brings component makers and MSMEs into the incentive framework, with higher incentives for critical components and high-end devices to deepen localisation

Drug pricing regulator NPPA asks state drug controllers to submit action-taken reports by November 16 as a 30 per cent trade margin cap on 137 cancer drugs takes effect

Despite progress, India still had the highest TB burden, accounting for almost a quarter of global cases in 2025

The revised scheme removes the minimum sales threshold, lowers investment requirements and offers higher incentives for critical components and advanced medical devices

Delhi's AQI touched 372 on Monday after Diwali celebrations, triggering health concerns, questions over pollution monitoring and a political row over stubble burning in Punjab

Fortis Healthcare's Q2FY27 net profit declined to ₹320 crore as expenses rose, while revenue grew 17 per cent to ₹2,735 crore, driven by hospitals and diagnostics

The Health Ministry has proposed suspending manufacturing licences immediately after drugs fail critical quality tests, aiming to prevent unsafe medicines from remaining in circulation.

The Union Health Ministry has proposed tightening microbial contamination limits in Grade A clean areas to align India's pharmaceutical manufacturing standards with WHO guidelines

Manipal Health Enterprises will develop and operate a multi-specialty hospital on 3.5 acres in Gurugram under a 30-year lease, with the estimated investment pegged at ₹750 crore

Dr Lal PathLabs reported a 19.6 per cent rise in Q2FY27 revenue to ₹874 crore as sample volumes grew 13.6 per cent and patient coverage increased 9 per cent

The Health Ministry proposes adding seven inland container depots, an SEZ and Jewar airport to the approved list to ease imports of drugs, medical devices and cosmetics

The proposed amendments seek to strengthen accountability in drug manufacturing by requiring qualified personnel for batch release and maintaining prescribed records

Pharma executives seek clarity on export applicability of CDSCO's batch-wise solvent clearance rules, warning that approval delays could disrupt supplies, particularly in rural markets

Drug regulator CDSCO has mandated digital clearance for every batch of high-risk pharmaceutical solvents, prompting industry concerns over delays and potential supply disruptions

The drugmaker plans to deploy ₹500 crore for another acquisition within 12 months as it targets 25 per cent annual growth in its API business over the next five years

The Health Ministry has replaced the 60 per cent residual shelf-life requirement with a fixed 12-month minimum for most imported drugs, aiming to ease imports and reduce wastage

Max Healthcare's Q2FY27 net profit declined 15.6 per cent to ₹414.45 crore as operating and tax expenses rose, even as revenue grew 16.8 per cent on higher patient demand.

India's pharmaceutical exports rose 4.9 per cent to $16.14 billion in H1FY27, driven by growth in Europe, ASEAN and Latin America, even as shipments to the US moderated.

India's pharma and healthcare sector recorded 87 deals worth $4.3 billion in Q3 2026, as private equity activity surged and public market fundraising gained momentum.

Major innovator brands see no price reductions despite cuts of up to 93 per cent for some cancer medicines; patient groups say PAP exclusions and data gaps have diluted relief